Journals / Eastern Journal of Medicine / 2021 / Cilt: 26 - Sayı: 1

The Efficiency of MRI Technique In Determining The Depth of Myometrial Invasion In Endometrial Cancer

Pages
40–46
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Magnetic resonance imaging is an efficient imaging method in the preoperative evaluation of the depth of myometrial invasion in endometrial cancer

📌 3 Key Takeaways

🎯
Objective & Hypothesis:The aim of the present study was to determine the efficiency of preoperative magnetic resonance imaging investigation in the determination of the depth of myometrial invasion in endometrial cancer. 41 cases diagnosed with endometrial cancer via endometrial sampling and who underwent investigation with magnetic resonance imaging in preoperative period so as to determine the depth of myometrial invasion were evaluated retrospectively.
📊
Key Findings & Data:Mean age of the patients was 60.5±10.18 (43-86).
💡
Conclusion & Impact:Magnetic resonance imaging is an efficient imaging method in the preoperative evaluation of the depth of myometrial invasion in endometrial cancer
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Özet

The aim of the present study was to determine the efficiency of preoperative magnetic resonance imaging investigation in the determination of the depth of myometrial invasion in endometrial cancer. 41 cases diagnosed with endometrial cancer via endometrial sampling and who underwent investigation with magnetic resonance imaging in preoperative period so as to determine the depth of myometrial invasion were evaluated retrospectively. Imaging and operation data and pathology results were re trieved from hospital files. Mean age of the patients was 60.5±10.18 (43-86). As surgical procedure, they underwent total abdominal hysterectomy and bilateral salpingoophorectomy, bilateral pelvic lymph node dissection ± paraaortic lymph node dissection. Preoperative magnetic resonance imaging findings were compared with postoperative histology results and sensitivity of magnetic resonance imaging was found to be 68.2%, specificity 84.5%, PPD 68.2% and NPD 84.5% in the evaluation of the depth of myometrial invasion. Magnetic resonance imaging is an efficient imaging method in the preoperative evaluation of the depth of myometrial invasion in endometrial cancer

🔖

Cite This Article

YILDIZ, G., TURAN, K., YILDIZ, P. (2021). The Efficiency of MRI Technique In Determining The Depth of Myometrial Invasion In Endometrial Cancer. Eastern Journal of Medicine, Cilt: 26 - Sayı: 1, 40–46. https://ajindex.com/articles/208130

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (16)

  1. Howlader N, Noone AM, Krapcho M, Garshell J, Miller D, Altekruse SF, et al. "SEER cancer statistics review." National Cancer Institute 2008
  2. Gultekin, M, et al. Trends of Gynecological Cancers in Turkey: Toward Europe or Asia? Int J Gynecol Cancer 2017; 27: S1-S9
  3. Jemal, Ahmedin, et al. "Global cancer statistics." CA: a cancer journal for clinicians 2011; 61.2: 69-90
  4. Gallup DG, Stock RJ. Adenocarcinoma of the endometrium in women 40 years of age or younger. Obstet Gynecol 1984; 64: 417-420
  5. Carneiro MM, Lamaita RM, Ferreira MC, et al. Fertility preservation in endometrial cancer: is it safe? Review of the literature JBRA Assist Reprod V 20 no 4 2016
  6. Amant F, Moerman P, Neven P, Timmerman D, Van Limbergen E, Vergote I. Endometrial cancer. Lancet 2005; 366: 491-505
  7. Cicchillitti L, Corrado G, Carosi M, et al. Lamin A as novel molecular prognostic biomarker for EC. It J Gynaecol Obstet 2016; 28: N. 2
  8. Bogani G, Dowdy SC, Cliby WA, et al Management of endometrial cancer: issues and controversies. Eur J Gynaecol Oncol 2016; 37: 6- 12
  9. Caponio MA, Addati T, Popescu O, et al. P16INK4a protein expression in endocervical, endometrial and metastatic adenocarcinomas of extra-uterine origin: Diagnostic and clinical consideration. CancerBiomarkers 2014; 14: 169175
  10. American College of Obstetricians and Gynocologists: Tamoxsifen and uterin cancer. Committee Opinion 2006; 1475-1478
  11. Feldman, S. A. R. A. H., ROSS S. Berkowitz, and A. N. Tosteson. "Cost-effectiveness of strategies to evaluate postmenopausal bleeding." Obstetrics and gynecology 1993; 968-975
  12. Gordon, S. J., and J. Westgate. "The incidence and management of failed Pipelle sampling in a general outpatient clinic." Australian and New Zealand journal of obstetrics and gynaecology 1999; 115-118
  13. Mac Kenzie I, Bibby J. Critical assessment of dilatation and curettage in 1029 women. Lancet 1978; 566-568
  14. Obermair, Andreas, et al. "Does hysteroscopy facilitate tumor cell dissemination? Incidence of peritoneal cytology from patients with early stage endometrial carcinoma following dilatation and curettage (D & C) versus hysteroscopy and D & C." Cancer 2000; 139-143
  15. Cicinelli, Ettore, et al. "Risk of long-term pelvic recurrences after fluid minihysteroscopy in women with endometrial carcinoma: a controlled randomized study." Menopause 2010;17: 511-515
  16. Mutch, David G. "The new FIGO staging system for cancers of the vulva, cervix, endometrium and sarcomas." Gyne